Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Kimberly Nieman"'
Autor:
Paul J. Dluzniewski, James B. Wetmore, Haifeng Guo, Kimberly Nieman, David T. Gilbertson, Brian D. Bradbury, J. Michael Sprafka, Yi Peng, Tzu-Chieh Lin, Jiannong Liu
Publikováno v:
Pharmacoepidemiology and Drug Safety. 31:141-148
Purpose Secondary hyperparathyroidism (SHPT) is common among dialysis patients, and calcimimetics are a mainstay of treatment. This study assessed whether cinacalcet use is associated with gastrointestinal bleeding in a large hemodialysis cohort. Met
Publikováno v:
Clinical Nephrology. 86:262-269
Aims: Standardized mortality and hospitalization ratios (SMRs, SHRs) are used to measure dialysis facility performance in the US, with adjustment for demographics and comorbid conditions derived from the end-stage renal disease (ESRD) Medical Evidenc
Hospitalization in Daily Home Hemodialysis and Matched Thrice-Weekly In-Center Hemodialysis Patients
Publikováno v:
American Journal of Kidney Diseases. 65:98-108
Background Cardiovascular disease is a common cause of hospitalization in dialysis patients. Daily hemodialysis improves some parameters of cardiovascular function, but whether it associates with lower hospitalization risk is unclear. Study Design Ob
Autor:
Kimberly Nieman, David Zaun, Ryan D. Kilpatrick, Jiannong Liu, Craig A. Solid, Britt B. Newsome, Wendy L. St. Peter
Publikováno v:
American Journal of Nephrology. 37:389-398
Background/Aims: Data describing real-world use and effectiveness of cinacalcet are limited. We aimed to characterize predictors of treatment and changes in secondary hyperparathyroidism (SHPT) biochemistry after cinacalcet initiation. Methods: We st
Autor:
Ryan D. Kilpatrick, Jiannong Liu, David Zaun, Kimberly Nieman, Britt B. Newsome, Wendy L. St. Peter, Craig A. Solid
Publikováno v:
American Journal of Nephrology. 38:104-114
Background/Aims: African-Americans with end-stage renal disease receiving dialysis have more severe secondary hyperparathyroidism than Whites. We aimed to assess racial differences in clinical use of cinacalcet. Methods: This retrospective cohort stu
Autor:
Heidi S. Wirtz, Allan J. Collins, Jiannong Liu, David T. Gilbertson, James B. Wetmore, Kimberly Nieman, Brian D. Bradbury, Kerry Cooper
Fractures are a major source of morbidity and mortality in patients receiving dialysis. We sought to determine whether rates of fractures and tendon ruptures vary geographically.Data from the US Renal Data System were used to create four yearly cohor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c6e02635adf8112a0bf2f8f6b8afe45c
https://europepmc.org/articles/PMC4974888/
https://europepmc.org/articles/PMC4974888/
Autor:
Akeem A. Yusuf, Thy P. Do, Kimberly Nieman, Kimberly Lowe, Jiannong Liu, Brian D. Bradbury, Allan J. Collins, Wendy L. St. Peter
Publikováno v:
BMC Nephrology
Background Cinacalcet reduces parathyroid hormone (PTH) levels in patients receiving hemodialysis, but no non-experimental studies have evaluated the association between changes in PTH levels following cinacalcet initiation and clinical outcomes. We
Publikováno v:
Shock. 19:321-327
Lipopolysaccharide (LPS) stimulation of macrophages or monocytes is believed to occur via a serum- and CD14-dependent signaling pathway via toll-like receptor 4 (TLR4). We sought to determine whether serum and/or CD14 are required for LPS to induce t
Publikováno v:
The Journal of Trauma: Injury, Infection, and Critical Care. 49:806-814
Background: Dysregulation of monocyte/macrophage cytokine production after exposure to multiple inflammatory stimuli may contribute to multiple organ failure and sepsis. Endotoxin (lipopolysaccharide [LPS]) activation of murine macrophage results in
Autor:
Martha S. Persky, Geoffrey A. Block, Wendy L. St. Peter, Jiannong Liu, Qi Li, Cheryl Arko, Kimberly Nieman
Background and objectives: Cinacalcet was introduced in mid-2004 to treat secondary hyperparathyroidism in dialysis patients. We aimed to characterize adult patients who received cinacalcet prescriptions and to determine (1) dosage titration and effe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1759ce71a3326c38e3716881908c2231
https://europepmc.org/articles/PMC2637594/
https://europepmc.org/articles/PMC2637594/